Correlation Between Hepion Pharmaceuticals and Ginkgo Bioworks
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Ginkgo Bioworks.
Diversification Opportunities for Hepion Pharmaceuticals and Ginkgo Bioworks
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Hepion and Ginkgo is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Ginkgo Bioworks go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Ginkgo Bioworks
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 1.46 times more return on investment than Ginkgo Bioworks. However, Hepion Pharmaceuticals is 1.46 times more volatile than Ginkgo Bioworks Holdings. It trades about -0.02 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.05 per unit of risk. If you would invest 762.00 in Hepion Pharmaceuticals on August 26, 2024 and sell it today you would lose (696.00) from holding Hepion Pharmaceuticals or give up 91.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Ginkgo Bioworks Holdings
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Ginkgo Bioworks Holdings |
Hepion Pharmaceuticals and Ginkgo Bioworks Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Ginkgo Bioworks
The main advantage of trading using opposite Hepion Pharmaceuticals and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Ginkgo Bioworks vs. Eliem Therapeutics | Ginkgo Bioworks vs. HCW Biologics | Ginkgo Bioworks vs. Scpharmaceuticals | Ginkgo Bioworks vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |